COMPLEMENTARY THERAPY

Axona represents a novel approach to managing Alzheimer's disease. As the first and only prescription medical food product for patients with mild to moderate Alzheimer's disease, Axona meets the distinctive nutritional requirements of Alzheimer’s disease by providing an alternative source of energy to brain cells. Axona has been designed to complement existing Alzheimer’s therapies. Patients in clinical trials were permitted to take commonly prescribed Alzheimer’s disease medications, and additional improvements following Axona administration were observed even for those patients who were taking these other medications.